Saturday 17 October 2026 Export TENX’s income statement to Excel — free account

Tenax Therapeutics, Inc.

In the quarter to June 2026, EPS fell 29.6% and free cash flow fell 125.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.36 0.15 −9.93%

Follow TENX

Alert me

Market cap: $56.5M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: 1.79
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(44.80%)	(55.64%)	(51.71%)	(59.80%)
ROA Full definition →		(42.77%)	(52.36%)	(49.23%)	(57.02%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(45.03%)	(54.19%)	(50.49%)	(57.10%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(0.65)	(0.91)	(0.84)	(0.90)
Free Cash Flow Full definition →		(25.91)	(35.80)	(38.14)	(46.03)
Other line items
Cash ROIC Full definition →		(13.25%)	(18.39%)	(16.34%)	(19.88%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		—	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.60	0.68	0.66	0.71
Depreciation/Fixed assets Full definition →		0.00	—	—	—
Capex/Depreciation Full definition →		0.00	—	—	—
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.65)	(0.91)	(0.84)	(0.90)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly